-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cumulative amount of the reporting entity's undistributed earnings or deficit.
-
Summary
-
Chromocell Therapeutics Corp quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2022 to 2024.
- Chromocell Therapeutics Corp Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$16.1 M.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)